- Home
- FTFT vs ERNA Comparison
FTFT vs ERNA Comparison
Compare FTFT & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTFT | ERNA |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 10.0M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FTFT | ERNA |
|---|---|---|
| Price | $1.63 | $0.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.8K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.14 | 20.10 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,158,125.00 | $582,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 755.88 |
| 52 Week Low | $0.17 | $0.15 |
| 52 Week High | $4.03 | $3.00 |
Technical Indicators
Market Signals| Indicator | FTFT | ERNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 24.38 |
| Support Level | $1.42 | $0.33 |
| Resistance Level | $1.74 | $0.40 |
| Average True Range (ATR) | 0.19 | 0.09 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 35.08 | 7.21 |
Price Performance
Historical ComparisonAbout FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.